Longitudinal micro-CT-derived biomarkers: the new standard readouts for preclinical evaluation of pulmonary fibrosis and therapy

K. Dekoster (Leuven, Belgium), T. Decaesteker (Leuven, Belgium), N. Berghen (Leuven, Belgium), A. Jonckheere (Leuven, Belgium), J. Wouters (Leuven, Belgium), R. Lories (Leuven, Belgium), P. Hoet (Leuven, Belgium), J. Vanoirbeek (Leuven, Belgium), G. Vande Velde (Leuven, Belgium)

Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Session: Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Session type: Poster Discussion
Number: 1960
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Dekoster (Leuven, Belgium), T. Decaesteker (Leuven, Belgium), N. Berghen (Leuven, Belgium), A. Jonckheere (Leuven, Belgium), J. Wouters (Leuven, Belgium), R. Lories (Leuven, Belgium), P. Hoet (Leuven, Belgium), J. Vanoirbeek (Leuven, Belgium), G. Vande Velde (Leuven, Belgium). Longitudinal micro-CT-derived biomarkers: the new standard readouts for preclinical evaluation of pulmonary fibrosis and therapy. 1960

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Novel imaging biomarkers for assessment of lung fibrosis and inflammation
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021


Longitudinal micro-CT of preclinical models of lung disease provides biomarkers of disease and therapy that reveal compensatory changes in lung volume
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015

Evaluation of recently validated non-invasive formula using basic lung functions as a new screening tool for pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009


Preclinical models and imaging biomarkers of lung injury and disease
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021


Combined assessment of regional lung function and morphology using a contrast enhanced Dual-Energy CT protocol: Prospective value of functional imaging biomarkers in longitudinal analysis of patients with Interstitial Lung Disease
Source: Virtual Congress 2020 – What is new in interstitial lung diseases of known origin?
Year: 2020




Longitudinal assessment of lung fibrosis by micro CT correlates with histological evaluation in bleomycin-induced mice
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016


Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (3) 00019-2016; 10.1183/23120541.00019-2016
Year: 2017



Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis?
Source: Eur Respir J 2016; 48: 1271-1273
Year: 2016


Validation of a novel prognostic tool for idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015



Non-invasive diagnosis of lymphangioleiomyomatosis: new biomarkers
Source: International Congress 2018 – Russian Speaking Programme 2018: Part II
Year: 2018


PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery
Source: Eur Respir Rev 2013; 22: 148-152
Year: 2013



Monitoring asthma: state-of-the-art physiological, imaging, and biomarker assessments
Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2016



Non-invasive estimation of pulmonary artery pressure and resistance with CMR imaging: Derivation and prospective validation cohort study
Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation
Year: 2012


Validation of CALIPER (Computer-aided lung informatics for pathology evaluation and rating) for the non-invasive assessment of pulmonary nodules of the adenocarcinoma spectrum
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments
Source: International Congress 2015 – PG2 Asthma and COPD
Year: 2015

Extent of fibrosis by high-resolution computed tomography does not improve prediction of mortality in idiopathic pulmonary fibrosis when added to a simple clinical prediction model
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012